TORNTPHARM shows sign of weakness as investors do cost averaging
23 Apr, 20245 min read
TORNTPHARM ranked better than it's peers today. On a longer term basis, investors in TORRENT PHARMACEUTICALS L made +0.1% per day. Tuesday's performance of +3.86% was a outperformance compared to it's daily average.